APA (7th ed.) Citation

Maslah, N., Rety, S., Bonnamy, M., Aguinaga, L., Huynh, T., Parietti, V., . . . Cassinat, B. (2024). Niclosamide combined to Azacitidine to target TP53-mutated MDS/AML cells. Leukemia, 38(7), 1630. https://doi.org/10.1038/s41375-024-02281-z

Chicago Style (17th ed.) Citation

Maslah, Nabih, Salome Rety, Melina Bonnamy, Lorea Aguinaga, Tony Huynh, Veronique Parietti, Stephane Giraudier, Pierre Fenaux, and Bruno Cassinat. "Niclosamide Combined to Azacitidine to Target TP53-mutated MDS/AML Cells." Leukemia 38, no. 7 (2024): 1630. https://doi.org/10.1038/s41375-024-02281-z.

MLA (9th ed.) Citation

Maslah, Nabih, et al. "Niclosamide Combined to Azacitidine to Target TP53-mutated MDS/AML Cells." Leukemia, vol. 38, no. 7, 2024, p. 1630, https://doi.org/10.1038/s41375-024-02281-z.